We Are Excited to Announce the Arrival of Canigen^® Bb, A New Injectable Bordetella Bronchiseptica Vaccine for Dogs

Canigen^® Bb, an inactivated subunit vaccine, provides active immunisation against Bordetella bronchiseptica in dogs to reduce clinical signs of upper respiratory tract disease, whilst also reducing bacterial shedding post-infection.

Administered via subcutaneous injection, Canigen^® Bb offers clinicians a new tool in the fight against kennel cough in dogs where intra-nasal Bordetella bronchiseptica vaccination is not possible or preferred.

Licensed for use in dogs from 6 weeks of age, Canigen^® Bb extends protection against Bordetella bronchiseptica in dogs vaccinated with Canigen^® KC in the last 12 months for a further year with a single dose.

Canine infectious respiratory disease (CIRD), otherwise known as kennel cough or infectious tracheobronchitis, is widely recognised as one of the most common infectious diseases in dogs¹. Bordetella bronchiseptica is a clinically significant pathogen for the disease with 78.7% of dogs with acute respiratory signs testing positive for the bacteria².  45.6% of clinically healthy dogs also tested positive for Bordetella bronchiseptica, illustrating that clinically healthy dogs can carry respiratory pathogens and could act as sources of infection for susceptible dogs².

‘Canigen^® Bb offers clinicians an ideal solution to provide protection against Bordetella bronchiseptica in dogs where, for whatever reason, administering an intra-nasal vaccine is difficult or in pets who are in contact with known immunocompromised individuals where a live aerosolised vaccine may be less appropriate’ said Andrew Connolly, Marketing Director – UK & Ireland at Virbac. ‘It is our hope that Canigen^® Bb will increase the overall uptake of Bordetella bronchiseptica vaccination to provide increased protection against this widely prevalent and clinically significant disease’.

Canigen^®Bb is conveniently presented as a ready to use formula in a 10ml multi-dose bottle and can be stored at room temperature (2°C - 25°C) for up to 4 weeks once broached. It can be administered concurrently (at the same time but separate injections) with Canigen^® DHP, Canigen^® DHPPi, Canigen^® Pi & Canigen^® Lepto 4.

_{References:
1. Buonavoglia C., Martella V. Canine respiratory viruses. Veterinary Research. 2007; 38:355–373
2. Schulz BS, Kurz S, Weber K, Balzer HJ, Hartmann K. Detection of respiratory viruses and Bordetella bronchiseptica in dogs with acute respiratory tract infections. Vet J. 2014 Sep; 201(3):365-9.}